OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
All‐Trans‐Retinoic Acid‐Adjuvanted mRNA Vaccine Induces Mucosal Anti‐Tumor Immune Responses for Treating Colorectal Cancer
Wei Li, Yijia Li, Jingjiao Li, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 10
Wei Li, Yijia Li, Jingjiao Li, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 10
Showing 10 citing articles:
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 16
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 16
Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
Lei‐Ming Cao, Yifu Yu, Zi‐Zhan Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Lei‐Ming Cao, Yifu Yu, Zi‐Zhan Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems
Zhongyan Wu, Weilu Sun, Hailong Qi
Vaccines (2024) Vol. 12, Iss. 8, pp. 873-873
Open Access | Times Cited: 8
Zhongyan Wu, Weilu Sun, Hailong Qi
Vaccines (2024) Vol. 12, Iss. 8, pp. 873-873
Open Access | Times Cited: 8
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends
Yu Gao, Liang Yang, Zhenning Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Yu Gao, Liang Yang, Zhenning Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Recent Advances in the Development and Efficacy of Anti-Cancer Vaccines—A Narrative Review
Kajetan Kiełbowski, Paulina Plewa, Jan Zadworny, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 237-237
Open Access
Kajetan Kiełbowski, Paulina Plewa, Jan Zadworny, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 237-237
Open Access
Advances in cancer nanovaccines: a focus on colorectal cancer
Yalda Ghazizadeh, Hossein Salehi Shadkami, Fatemeh Madani, et al.
Nanomedicine (2025), pp. 1-13
Closed Access
Yalda Ghazizadeh, Hossein Salehi Shadkami, Fatemeh Madani, et al.
Nanomedicine (2025), pp. 1-13
Closed Access
Opportunities and Challenges for Nanomaterials as Vaccine Adjuvants
Zongda Li, Panpan Chen, Aihua Qu, et al.
Small Methods (2025)
Closed Access
Zongda Li, Panpan Chen, Aihua Qu, et al.
Small Methods (2025)
Closed Access
Tamibarotene-Loaded Nanoemulsion Incorporating Toll-like Receptor 2/6 Agonist as an Intramuscular Adjuvant System Enhances Gastrointestinal Mucosal Immunity
Yan Deng, Hao Cheng, Ji Zhu, et al.
ACS Nano (2025)
Closed Access
Yan Deng, Hao Cheng, Ji Zhu, et al.
ACS Nano (2025)
Closed Access
